These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 9469374)
1. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. Crump M; Gluck S; Pritchard K; Shepherd L; Pater J J Clin Oncol; 1998 Feb; 16(2):800-2. PubMed ID: 9469374 [No Abstract] [Full Text] [Related]
2. High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed. Vogl DT; Stadtmauer EA Bone Marrow Transplant; 2006 Jun; 37(11):985-7. PubMed ID: 16708060 [No Abstract] [Full Text] [Related]
3. High-dose chemotherapy and autologous bone marrow plus peripheral blood stem cell transplantation for patients with lymphoma or metastatic breast cancer: use of marker genes to investigate hematopoietic reconstitution in adults. Douer D; Levine A; Anderson WF; Gordon M; Groshen S; Khan A; Mohrbacher A; Muggia F; Shibata D Hum Gene Ther; 1996 Mar; 7(5):669-84. PubMed ID: 8845392 [No Abstract] [Full Text] [Related]
4. Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal? Cheng YC; Ueno NT Womens Health (Lond); 2010 Jul; 6(4):481-5. PubMed ID: 20597609 [No Abstract] [Full Text] [Related]
5. Quantitative assessment of colony growth and hematologic engraftment in patients undergoing high-dose chemotherapy and autologous bone marrow transplantation for breast cancer. Meehan KR; Ericson SG; Tosteson TD; Mills LE Prog Clin Biol Res; 1994; 389():497-503. PubMed ID: 7535459 [No Abstract] [Full Text] [Related]
6. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. Antman KH; Rowlings PA; Vaughan WP; Pelz CJ; Fay JW; Fields KK; Freytes CO; Gale RP; Hillner BE; Holland HK; Kennedy MJ; Klein JP; Lazarus HM; McCarthy PL; Saez R; Spitzer G; Stadtmauer EA; Williams SF; Wolff S; Sobocinski KA; Armitage JO; Horowitz MM J Clin Oncol; 1997 May; 15(5):1870-9. PubMed ID: 9164197 [TBL] [Abstract][Full Text] [Related]
7. Role of high-dose chemotherapy and autologous stem cell support in treatment of breast cancer. Myers SE; Williams SF Hematol Oncol Clin North Am; 1993 Jun; 7(3):631-45. PubMed ID: 8102137 [TBL] [Abstract][Full Text] [Related]
8. CD34 may be used to determine the adequacy of a stem cell harvest for hematologic recovery following high dose chemotherapy. Zimmerman TM; Lee WJ; Bender JG; Mick R; Williams SF Prog Clin Biol Res; 1994; 389():303-8. PubMed ID: 7535435 [No Abstract] [Full Text] [Related]
9. High-dose chemotherapy and autologous stem cell transplantation for breast cancer. Weaver CH; Birch R; Schwartzberg LS; West WH Cancer Treat Res; 1995; 76():59-85. PubMed ID: 7577345 [No Abstract] [Full Text] [Related]
10. High-dose chemotherapy and stem-cell support in breast cancer. Pedrazzoli P; Da Prada GA; Robustelli della Cuna G Lancet; 1998 Oct; 352(9135):1220. PubMed ID: 9777858 [No Abstract] [Full Text] [Related]
11. Does high-dose chemotherapy have a defined role in the treatment of solid tumors in 1997? Weaver CH; Snyder MJ; Nichols WC Semin Oncol; 1997 Aug; 24(4):xxxi, xxxvii-xxxviii. PubMed ID: 9280216 [No Abstract] [Full Text] [Related]
12. Analysis of dose-response relationships in the setting of high-dose ifosfamide, carboplatin, and etoposide and autologous hematopoietic stem cell transplantation: implications for the treatment of patients with advanced breast cancer. Perkins JB; Effenbein GJ; Fields KK Semin Oncol; 1996 Jun; 23(3 Suppl 6):42-6. PubMed ID: 8677448 [TBL] [Abstract][Full Text] [Related]
13. Intensive chemotherapy with autologous peripheral-blood stem-cell rescue in metastatic breast cancer. Dillman RO; Barth NM J Clin Oncol; 1994 Oct; 12(10):2237. PubMed ID: 7931496 [No Abstract] [Full Text] [Related]
14. Clinical protocol. Purging of autologous stem cell sources with bcl-x(s) adenovirus for women undergoing high-dose chemotherapy for stage IV breast carcinoma. Ayash LJ; Clarke M; Adams P; Ferrara J; Ratanatharathorn V; Reynolds C; Roessler B; Silver S; Strawderman M; Uberti J; Wicha M Hum Gene Ther; 2001 Nov; 12(16):2023-5. PubMed ID: 11727734 [TBL] [Abstract][Full Text] [Related]
15. [High dose chemotherapy with autologous stem cell support in cancer patients]. Abrahamsen JF; Kristoffersen EK; Hervig T; Ekanger R; Nesthus I; Ulvestad E Tidsskr Nor Laegeforen; 2000 May; 120(13):1523-8. PubMed ID: 10916472 [TBL] [Abstract][Full Text] [Related]
17. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer. Peters WP; Ross M; Vredenburgh JJ; Hussein A; Rubin P; Dukelow K; Cavanaugh C; Beauvais R; Kasprzak S Semin Oncol; 1994 Aug; 21(4 Suppl 7):25-31. PubMed ID: 7916487 [TBL] [Abstract][Full Text] [Related]
18. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study]. Shi Y; Pan F; Han X Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500 [TBL] [Abstract][Full Text] [Related]
19. High-dose therapy in breast cancer: out of favor but not out of promise. Glück S; Stewart D Bone Marrow Transplant; 2000 May; 25(10):1017-9. PubMed ID: 10828859 [TBL] [Abstract][Full Text] [Related]
20. Breast cancer studies yield mixed results on high-dose chemotherapy with stem cell support. Miller SL Am J Health Syst Pharm; 1999 May; 56(10):939. PubMed ID: 10365714 [No Abstract] [Full Text] [Related] [Next] [New Search]